Skip to main content
. 2018 Nov 3;16:299. doi: 10.1186/s12967-018-1675-4

Table 3.

Medications of all patients at baseline—responders and non-responders

All (N = 61) Responders (N = 49) Non-responders (N = 12) p*
ß-blockers 55 (90%) 45 (92%) 10 (83%) 0.40
ACE or ARB 61 (100%) 49 (100%) 12 (100%)
MRA 43 (70%) 36 (73%) 7 (58%) 0.31
Diuretics 46 (75%) 37 (76%) 9 (76%) 0.97
Anticoagulant 6 (10%) 5 (10%) 1 (8%) 0.84
Antiplatelet therapy 38 (62%) 20 (41%) 9 (75%) 0.30

*A p value ≤ 0.05 was considered significant